For medical or financial reasons, bilateral cochlear implantation is not always possible in bilaterally deafened patients. In such cases, a contralateral routing of signals (CROS) device could complement the monaural implant. The goal of our study was to compare the benefit of three different conditions: (1) unilateral cochlear implant (CI) alone, (2) unilateral CI complemented with a directional CROS microphone, and (3) bilateral CIs.
Twelve bilateral experienced CI users were tested. Speech reception in noise and sound localization were measured in the three above-mentioned conditions. Patients evaluated which condition they presumed to be activated and the subjective benefit on a hearing scale.
Compared with the unilateral CI condition, the additional CROS device provided significantly better speech intelligibility in noise when speech signals came from the front or side of the CROS microphone. Only small subjective improvement was observed. Bilateral-activated CIs further improved the hearing performance. This was the only condition where sound localization was possible. Subjective evaluation showed a clear preference for the bilateral CI treatment.
In bilateral deafened patients, bilateral implantation is the most preferable form of treatment. However, patients with one implant only could benefit from an additional directional microphone CROS device.
Supplemental Digital Content is available in the text.
1Department of ENT, Head and Neck Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; 2Artificial Hearing Research, ARTORG Center for Biomedical Engineering Research, University of Bern, Switzerland; and 3Department of ENT, Head and Neck Surgery, University Hospital Basel, Basel, Switzerland.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and text of this article on the journal’s Web site (www.ear-hearing.com).
The authors have no conflicts of interest to disclose.
Received August 17, 2016; accepted December 1, 2016.
Address for correspondence: Wilhelm Wimmer, Artificial Hearing Research, ARTORG Center for Biomedical Engineering Research, Murtenstrasse 50, University of Bern, Bern CH-3008, Switzerland. E-mail: firstname.lastname@example.org